Results 181 to 190 of about 40,075 (233)

Haemophilus influenzae Type b Conjugate Vaccines

1995
In summary, all of the Hib conjugate vaccines are highly immunogenic and efficacious in children older than 12-15 months of age, and HbOC, PRP-OMPC, and PRP-T are highly immunogenic and demonstrated to be efficacious in infants as young as 2 months old.
P J, Kniskern, S, Marburg, R W, Ellis
openaire   +2 more sources

A decline in Haemophilus influenzae type b meningitis

The Journal of Pediatrics, 1993
During the past 50 years, there has been an unexplained fourfold increase in admissions for Haemophilus influenzae type b meningitis to the Children's Hospital of Pittsburgh, and an equally striking decline that cannot be attributed entirely to immunization.
R H, Michaels, O, Ali
openaire   +2 more sources

Haemophilus influenzae type b conjugate vaccine

Journal of Pediatric Health Care, 1988
Abstract Hib conjugate vaccine was developed with the ultimate goal of providing an effective vaccine for infants and younger children. The conjugate vaccine is as safe as Hib polysaccharide vaccine and significantly more immunogenic. Because antibody production after vaccination with conjugate vaccine in children 18 months of age or older is ...
J J, Campion, D T, Casto
openaire   +2 more sources

Ceftriaxone in Haemophilus influenzae Type b Meningitis

JAMA: The Journal of the American Medical Association, 1988
To the Editor. —Jacobs et al 1 report the first apparent case, to my knowledge, of a failure of ceftriaxone to sterilize cerebrospinal fluid (CSF) after three days of therapy in a child with Haemophilus influenzae type b pneumonia with sepsis. This information stands in contrast to a large body of clinical data in which ceftriaxone has been used to ...
openaire   +2 more sources

Haemophilus influenzae type b unsuspected bacteremia

Pediatric Emergency Care, 1987
To further define the clinical features and natural history of unsuspected Haemophilus influenzae type b (Hib) bacteremia, we retrospectively reviewed the records of 322 Hib infections observed during a 45-month period at Children's Hospital, Boston. We identified 31 patients with unsuspected Hib bacteremia and 19 with unsuspected Hib antigenemia and ...
A B, Anderson, D M, Ambrosino, G R, Siber   +2 more
openaire   +2 more sources

Effectiveness of vaccination for Haemophilus influenzae type b

The Lancet, 2003
Summary Several cases of invasive Haemophilus influenzae type b (Hib) infection have been identified in children previously vaccinated against this disease. We have reviewed all cases of Hib in Nottingham, UK, since the conjugated vaccine was introduced into the primary course of childhood immunisations in 1992.
David, Garner, Vivienne, Weston
openaire   +2 more sources

Haemophilus influenzae Type b Infections in Adults

Scandinavian Journal of Infectious Diseases, 1989
31 cases of invasive Haemophilus influenzae type b infections occurred in adults in Denmark during a period of 2 years and 5 months corresponding to an incidence of 0.3/100,000/year. Only 6 patients had no underlying condition. The incidence of H. influenzae type b infections in adults will probably rise in the future, because the increasing use of ...
openaire   +2 more sources

Ampicillin Resistance and Haemophilus influenzae Type b

Archives of Pediatrics & Adolescent Medicine, 1985
Sir .—Your commentary 1 states that "Ampicillin resistance has been demonstrated in nontype b strains although at a much lower level than that observed by type b organisms." The reference to Long et al 2 is provided to support that statement. I believe this is an incorrect statement and that the cited reference does not support it. The study of Long et
openaire   +2 more sources

Haemophilus influenzae type b vaccination

The Lancet, 1997
A, Melhus, A, Hemansson
openaire   +2 more sources

Prevention of Haemophilus influenzae type b disease

Vaccine, 1993
Haemophilus influenzae type b (Hib) is the leading cause of meningitis in children < 5 years of age. The majority of cases of Hib occur in infants < 2 years of age. Until recently the only vaccine available against this disease contained the pure polysaccharide (PRP) of Hib (Hib-PRP vaccine).
openaire   +2 more sources